Filter News
Area of Research
News Topics
- (-) Mercury (3)
- (-) Microscopy (1)
- (-) Nanotechnology (2)
- (-) Summit (3)
- 3-D Printing/Advanced Manufacturing (3)
- Advanced Reactors (1)
- Artificial Intelligence (3)
- Big Data (1)
- Bioenergy (8)
- Biology (14)
- Biomedical (5)
- Biotechnology (3)
- Buildings (2)
- Chemical Sciences (1)
- Clean Water (3)
- Climate Change (3)
- Computer Science (10)
- Coronavirus (1)
- Decarbonization (2)
- Energy Storage (4)
- Environment (20)
- Exascale Computing (1)
- High-Performance Computing (8)
- Materials (2)
- Materials Science (2)
- Neutron Science (3)
- Nuclear Energy (1)
- Physics (1)
- Quantum Computing (1)
- Quantum Science (1)
- Security (1)
- Sustainable Energy (6)
- Transportation (4)
Media Contacts
A team led by ORNL and the University of Michigan have discovered that certain bacteria can steal an essential compound from other microbes to break down methane and toxic methylmercury in the environment.
Anyone familiar with ORNL knows it’s a hub for world-class science. The nearly 33,000-acre space surrounding the lab is less known, but also unique.
Moving to landlocked Tennessee isn’t an obvious choice for most scientists with new doctorate degrees in coastal oceanography.
Improved data, models and analyses from ORNL scientists and many other researchers in the latest global climate assessment report provide new levels of certainty about what the future holds for the planet
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.
Through a consortium of Department of Energy national laboratories, ORNL scientists are applying their expertise to provide solutions that enable the commercialization of emission-free hydrogen fuel cell technology for heavy-duty
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
Since the 1930s, scientists have been using particle accelerators to gain insights into the structure of matter and the laws of physics that govern our world.